Company

resTORbio, Inc.

resTORbio, Inc. is a Boston biotechnology company developing therapeutics that target the aging process.

About

Its therapeutics aim to enhance health and longevity in older adults and address age-related disease. Founded in 2016 and headquartered in Boston, US, the company raised USD 85 mn in its IPO on January 25, 2018 and has completed three deals. It reported EBITDA of USD -85.33 mn in 2019. In September 2020 it merged with Adicet Bio, Inc., which now operates under the Adicet Bio name.

1Funding rounds

5Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in